Tivantinib alleviates inflammatory diseases by directly targeting NLRP3.

Huang, Yi; Guo, Yun; Zhou, Yan; Huang, Qian; Ru, Yi; Luo, Yingli; Xu, Wen.

Affiliation

Huang Y; Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Guo Y; Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Jiangnan University, 214023 Wuxi, Jiangsu, China.
Zhou Y; Department of Child Health Care, Anhui Provincial Children's Hospital/ Children's Hospital of Fudan University Anhui Hospital, Hefei 230051, China.
Huang Q; Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Ru Y; Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Luo Y; Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Xu W; Neurology Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

iScience ; 26(3): 106062, 2023 Mar 17.

Article in En | MEDLINE | ID: mdl-36843841